SEC Form 4 · accession 0001127602-17-027906
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & CEO · Director
Period of report
Sep 21, 2017
Accepted (ET)
Sep 22, 2017 · 8:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 21, 2017 | M | 1,274 | $30.75 | A | 2,343 | D | |
| Common StockF2 | Sep 21, 2017 | M | 902 | $30.75 | A | 674,320 | I | By Trusts |
| Common StockF3 | Sep 21, 2017 | S | 1,074 | $115.8254 | D | 1,269 | D | |
| Common StockF4 | Sep 21, 2017 | S | 200 | $117.36 | D | 1,069 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $30.75 | Sep 21, 2017 | M | 1,274 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 1,274 | 20,809 | D |
| Stock OptionsF2 | $30.75 | Sep 21, 2017 | M | 902 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 902 | 19,907 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. The transaction was structured as a broker-assisted cashless exercise, such that the number of shares sold was limited to a sufficient number to cover the exercise price of the options and anticipated taxes. The remaining shares are held by a trust beneficially owned by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $115.48 to $116.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $117.23 to $117.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.